Awakn Life Sciences Enters Global Licensing Agreement For Proprietary Sublingual S- Ketamine Formulation With LTS
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://sedar-filings-backup.thecse.com/00047220/2312200451089426.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts:
